Upender Velaparthi

Person

Cheshire, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridinone compounds useful as T cell activators
- Patent number 11,866,430
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-beta inhibitors
- Patent number 11,352,360
- Issue date Jun 7, 2022
- Rigel Pharmaceuticals, hic.
- Todd Kinsella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF beta receptor antagonists
- Patent number 10,961,239
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 10,287,295
- Issue date May 14, 2019
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GDF-8 inhibitors
- Patent number 9,981,944
- Issue date May 29, 2018
- Rigel Pharmaceuticals, Inc.
- Pingyu Ding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors
- Patent number 9,956,220
- Issue date May 1, 2018
- Bristol-Myers Squibb Company
- Upender Velaparthi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-beta inhibitors
- Patent number 9,884,868
- Issue date Feb 6, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...
- Patent number 9,598,423
- Issue date Mar 21, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoles as casein kinase 1 D/E inhibitors
- Patent number 9,556,179
- Issue date Jan 31, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibi...
- Patent number 9,475,817
- Issue date Oct 25, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
- Patent number 9,273,058
- Issue date Mar 1, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic heteroaryl compounds
- Patent number 9,242,967
- Issue date Jan 26, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazinyl compounds
- Patent number 9,145,419
- Issue date Sep 29, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds useful as CYP17 inhibitors
- Patent number 8,916,553
- Issue date Dec 23, 2014
- Bristol-Myers Squibb Company
- Joel Francis Austin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azaindazole compounds
- Patent number 8,673,922
- Issue date Mar 18, 2014
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine kinase inhibitors
- Patent number 8,592,579
- Issue date Nov 26, 2013
- Bristol-Myers Squibb Company
- Mark D. Wittman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazine kinase inhibitors
- Patent number 8,415,340
- Issue date Apr 9, 2013
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine kinase inhibitors
- Patent number 8,212,031
- Issue date Jul 3, 2012
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediate useful in preparing certain pyrrolotriazine compounds...
- Patent number 8,148,522
- Issue date Apr 3, 2012
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine kinase inhibitors
- Patent number 7,879,855
- Issue date Feb 1, 2011
- Bristol-Myers Squibb Company
- Mark D. Wittman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine kinase inhibitors
- Patent number 7,534,792
- Issue date May 19, 2009
- Bristol-Myers Squibb Company
- Mark D. Wittman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 7,470,696
- Issue date Dec 30, 2008
- Bristol-Myers Squibb Company
- Francis Beaulieu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 7,232,826
- Issue date Jun 19, 2007
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 7,223,757
- Issue date May 29, 2007
- Bristol-Myers Squibb Company
- Mark D. Wittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 7,189,716
- Issue date Mar 13, 2007
- Bristol-Myers Squibb Company
- Francis Beaulieu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12D INHIBITORS
- Publication number 20240317769
- Publication date Sep 26, 2024
- Bristol-Myers Squibb Company
- Brian Edward FINK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITORS
- Publication number 20240217982
- Publication date Jul 4, 2024
- Bristol-Myers Squibb Company
- Brian Edward FINK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
- Publication number 20240108654
- Publication date Apr 4, 2024
- Juno Therapeutics, Inc.
- David G. KUGLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS
- Publication number 20230118629
- Publication date Apr 20, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230094758
- Publication date Mar 30, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230086933
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...
- Publication number 20230061608
- Publication date Mar 2, 2023
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210277004
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20200031832
- Publication date Jan 30, 2020
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF BETA RECEPTOR ANTAGONISTS
- Publication number 20190337942
- Publication date Nov 7, 2019
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF Beta RECEPTOR ANTAGONISTS
- Publication number 20190292179
- Publication date Sep 26, 2019
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF BETA RECEPTOR ANTAGONISTS
- Publication number 20180250303
- Publication date Sep 6, 2018
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20180127426
- Publication date May 10, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO-PYRIDAZINE DERIVATIVES AS CASEIN KINASE 1 DELTA/EPSILON INH...
- Publication number 20170137427
- Publication date May 18, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES A...
- Publication number 20160311824
- Publication date Oct 27, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GDF-8 Inhibitors
- Publication number 20160264553
- Publication date Sep 15, 2016
- Rigel Pharmaceuticals, Inc.
- Pingyu Ding
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20160257690
- Publication date Sep 8, 2016
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20160122358
- Publication date May 5, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE SUBSTITUTED IMIDAZOPYRAZINES AS CASEIN KINASE 1 D/E INHIBI...
- Publication number 20150344480
- Publication date Dec 3, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS
- Publication number 20150344481
- Publication date Dec 3, 2015
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20150133428
- Publication date May 14, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS
- Publication number 20150126529
- Publication date May 7, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS
- Publication number 20140235647
- Publication date Aug 21, 2014
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY

Upender Velaparthi

Person

Patents Grantslast 30 patents

Substituted bicyclic compounds useful as T cell activators

Naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted pyridopyrimidinonyl compounds useful as T cell activators

TGF-beta inhibitors

TGF beta receptor antagonists

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

TGF-β inhibitors

GDF-8 inhibitors

Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors

TGF-beta inhibitors

Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...

Substituted imidazoles as casein kinase 1 D/E inhibitors

Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibi...

Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors

Substituted bicyclic heteroaryl compounds

Imidazopyridazinyl compounds

Sulfonamide compounds useful as CYP17 inhibitors

Azaindazole compounds

Pyrrolotriazine kinase inhibitors

Triazine kinase inhibitors

Pyrrolotriazine kinase inhibitors

Intermediate useful in preparing certain pyrrolotriazine compounds...

Pyrrolotriazine kinase inhibitors

Pyrrolotriazine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

KRAS G12D INHIBITORS

KRAS INHIBITORS

COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

TGF-Beta Inhibitors

TGF BETA RECEPTOR ANTAGONISTS

TGF Beta RECEPTOR ANTAGONISTS

TGF BETA RECEPTOR ANTAGONISTS

TGF-Beta Inhibitors

IMIDAZO-PYRIDAZINE DERIVATIVES AS CASEIN KINASE 1 DELTA/EPSILON INH...

SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES A...

GDF-8 Inhibitors

TGF-Beta Inhibitors

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

PYRAZOLE SUBSTITUTED IMIDAZOPYRAZINES AS CASEIN KINASE 1 D/E INHIBI...

NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 D/E INHIBITORS

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS